Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Good and Bad of Healthcare Reform

Stanley B. Cohen, MD  |  Issue: May 2010  |  May 1, 2010

The law also creates an approval pathway for biosimilar biologics. The ACR believes that, while cost savings are highly desirable, the approval process for biosimilars needs to place safety and efficacy, supported by scientific sound evidence, as its highest priorities.

Physician Reimbursement

The law hopes to increase the number of primary care physicians by increasing reimbursement to physicians who have a primary specialty designation of family medicine, internal medicine, geriatric medicine, or pediatric medicine. These physicians, along with nurse practitioners and physician assistants working in those areas, will see a 10% increase in their reimbursement if at least 60% of their services are provided as primary care services. Subspecialists have not been named in this section and therefore will not receive the increase.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Access for Medicare patients continues to falter as Congress continues to ignore the flawed sustainable growth rate (SGR) formula and costs for a permanent fix increase dramatically. Unfortunately, a fix for the SGR formula was not addressed in the new law. Physicians have had uncertainty throughout the year because Congress refuses to permanently repeal the flawed formula and continues to pass short-term fixes to Medicare reimbursement rates. This has made it impossible for physicians to run a practice with any certainty of their monthly gross income from Medicare patients. Several times CMS has held payments to physicians, allowing Congress more time to pass another band-aid. The time for band-aid fixes is now over. Physicians, health professionals, and patients must contact Congress to ensure that Medicare patients have access to care. With the baby boomers reaching Medicare eligibility, Congress cannot ignore the flawed formula and leave millions of Medicare patients without access to healthcare. Congress must fix the flawed SGR formula and guarantee appropriate reimbursement for physicians.

Healthcare reform is really just beginning. The law has been passed, but now the law must be implemented. The ACR will continue to advocate for physicians and our patients. We are staying abreast of the bill and know that as it unfolds we all will be trying to find access to care for the 32 million Americans who will now have healthcare insurance. To keep current on healthcare reform, I recommend you visit www.rheumatology.org.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Cohen is president of the ACR. Contact him via e-mail at [email protected].

Page: 1 2 3 | Single Page
Share: 

Filed under:Legislation & AdvocacyPresident's PerspectiveProfessional Topics Tagged with:Healthcare ReformLegislationMedicareQualityReimbursement

Related Articles

    What the Affordable Care Act Means for Rheumatology

    January 1, 2014

    Expected to flood the healthcare system with an influx of insured patients, Obamacare will likely exacerbate physician shortages, worsen capacity issues for many rheumatologists, and pressure providers to deliver a measurable quality of care, but analysts say rheumatology patients will benefit from expanded insurance coverage options

    ACR Advocacy: 2020 Year in Review

    January 11, 2021

    As a new year begins, Government Affairs Committee Chair Blair Solow, MD, takes stock of ACR advocacy wins in 2020 and issues to watch in 2021, including workforce issues, continued telemedicine access, prior authorization relief, Medicare reimbursement and drug pricing.

    President’s Perspective: ACR Addresses Reform of Sustainable Growth Rate Formula

    December 1, 2013

    The College’s multi-pronged plan to replace flawed SGR payment system requires continued support from rheumatologists, healthcare professionals

    ACR Joins Opposition to Proposed Healthcare Replacement Bill as Written

    March 16, 2017

    The ACR is joining a chorus of voices asking Congress to reconsider several key provisions in the proposed American Health Care Act (AHCA) that it feels could have a detrimental effect on patients. Characterized as a replacement to the Affordable Care Act (ACA), the AHCA eliminates a number of provisions found in the ACA, although…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences